Cefiderocol either in monotherapy or combination versus best available therapy in the treatment of carbapenem-resistant Acinetobacter baumannii infections: A systematic review and meta-analysis
Key Points
Key points are not available for this paper at this time.
Abstract
Our data strengthen the efficacy and safety profile of cefiderocol in CRAB infections.
Cefiderocol either in monotherapy or combination versus best available therapy in the treatment of carbapenem-resistant Acinetobacter baumannii infections: A systematic review and meta-analysis | Synapse